Apple (AAPL) 10-Q28 Jan 222022 Q1 Quarterly reportFinancial data

Company Profile

Cover Page

Cover Page - shares shares in Thousands	3 Months Ended
Cover Page - shares shares in Thousands	Dec. 25, 2021	Jan. 14, 2022
Entity Information [Line Items]
Document Type	10-Q
Document Quarterly Report	true
Document Period End Date	Dec. 25, 2021
Document Transition Report	false
Entity File Number	001-36743
Entity Registrant Name	Apple Inc.
Entity Incorporation, State or Country Code	CA
Entity Tax Identification Number	94-2404110
Entity Address, Address Line One	One Apple Park Way
Entity Address, City or Town	Cupertino
Entity Address, State or Province	CA
Entity Address, Postal Zip Code	95014
City Area Code	408
Local Phone Number	996-1010
Entity Current Reporting Status	Yes
Entity Interactive Data Current	Yes
Entity Filer Category	Large Accelerated Filer
Entity Small Business	false
Entity Emerging Growth Company	false
Entity Shell Company	false
Entity Common Stock, Shares Outstanding (in shares)		16,319,441
Amendment Flag	false
Document Fiscal Year Focus	2022
Document Fiscal Period Focus	Q1
Entity Central Index Key	0000320193
Current Fiscal Year End Date	--09-24
Common Stock
Entity Information [Line Items]
Title of 12(b) Security	Common Stock, $0.00001 par value per share
Trading Symbol	AAPL
Security Exchange Name	NASDAQ
1.000% Notes due 2022
Entity Information [Line Items]
Title of 12(b) Security	1.000% Notes due 2022
No Trading Symbol Flag	true
Security Exchange Name	NASDAQ
1.375% Notes due 2024
Entity Information [Line Items]
Title of 12(b) Security	1.375% Notes due 2024
No Trading Symbol Flag	true
Security Exchange Name	NASDAQ
0.000% Notes due 2025
Entity Information [Line Items]
Title of 12(b) Security	0.000% Notes due 2025
No Trading Symbol Flag	true
Security Exchange Name	NASDAQ
0.875% Notes due 2025
Entity Information [Line Items]
Title of 12(b) Security	0.875% Notes due 2025
No Trading Symbol Flag	true
Security Exchange Name	NASDAQ
1.625% Notes due 2026
Entity Information [Line Items]
Title of 12(b) Security	1.625% Notes due 2026
No Trading Symbol Flag	true
Security Exchange Name	NASDAQ
2.000% Notes due 2027
Entity Information [Line Items]
Title of 12(b) Security	2.000% Notes due 2027
No Trading Symbol Flag	true
Security Exchange Name	NASDAQ
1.375% Notes due 2029
Entity Information [Line Items]
Title of 12(b) Security	1.375% Notes due 2029
No Trading Symbol Flag	true
Security Exchange Name	NASDAQ
3.050% Notes due 2029
Entity Information [Line Items]
Title of 12(b) Security	3.050% Notes due 2029
No Trading Symbol Flag	true
Security Exchange Name	NASDAQ
0.500% Notes due 2031
Entity Information [Line Items]
Title of 12(b) Security	0.500% Notes due 2031
No Trading Symbol Flag	true
Security Exchange Name	NASDAQ
3.600% Notes due 2042
Entity Information [Line Items]
Title of 12(b) Security	3.600% Notes due 2042
No Trading Symbol Flag	true
Security Exchange Name	NASDAQ

CONDENSED CONSOLIDATED STATEMEN

CONDENSED CONSOLIDATED STATEMENTS OF OPERATIONS (Unaudited) - USD ($) shares in Thousands, $ in Millions	3 Months Ended
	Dec. 25, 2021	Dec. 26, 2020
Net sales	$ 123,945	$ 111,439
Cost of sales	69,702	67,111
Gross margin	54,243	44,328
Operating expenses:
Research and development	6,306	5,163
Selling, general and administrative	6,449	5,631
Total operating expenses	12,755	10,794
Operating income	41,488	33,534
Other income/(expense), net	(247)	45
Income before provision for income taxes	41,241	33,579
Provision for income taxes	6,611	4,824
Net income	$ 34,630	$ 28,755
Earnings Per Share [Abstract]
Basic (in dollars per share)	$ 2.11	$ 1.70
Diluted (in dollars per share)	$ 2.10	$ 1.68
Shares used in computing earnings per share:
Basic (in shares)	16,391,724	16,935,119
Diluted (in shares)	16,519,291	17,113,688
Products
Net sales	$ 104,429	$ 95,678
Cost of sales	64,309	62,130
Services
Net sales	19,516	15,761
Cost of sales	$ 5,393	$ 4,981

CONDENSED CONSOLIDATED STATEM_2

CONDENSED CONSOLIDATED STATEMENTS OF COMPREHENSIVE INCOME (Unaudited) - USD ($) $ in Millions	3 Months Ended
	Dec. 25, 2021	Dec. 26, 2020
Statement of Comprehensive Income [Abstract]
Net income	$ 34,630	$ 28,755
Other comprehensive income/(loss):
Change in foreign currency translation, net of tax	(360)	549
Change in unrealized gains/losses on derivative instruments, net of tax:
Change in fair value of derivative instruments	362	(304)
Adjustment for net (gains)/losses realized and included in net income	93	(183)
Total change in unrealized gains/losses on derivative instruments	455	(487)
Change in unrealized gains/losses on marketable debt securities, net of tax:
Change in fair value of marketable debt securities	(1,176)	628
Adjustment for net (gains)/losses realized and included in net income	(9)	(105)
Total change in unrealized gains/losses on marketable debt securities	(1,185)	523
Total other comprehensive income/(loss)	(1,090)	585
Total comprehensive income	$ 33,540	$ 29,340

CONDENSED CONSOLIDATED BALANCE

CONDENSED CONSOLIDATED BALANCE SHEETS (Unaudited) - USD ($) $ in Millions	Dec. 25, 2021	Sep. 25, 2021
Current assets:
Cash and cash equivalents	$ 37,119	$ 34,940
Marketable securities	26,794	27,699
Accounts receivable, net	30,213	26,278
Inventories	5,876	6,580
Vendor non-trade receivables	35,040	25,228
Other current assets	18,112	14,111
Total current assets	153,154	134,836
Non-current assets:
Marketable securities	138,683	127,877
Property, plant and equipment, net	39,245	39,440
Other non-current assets	50,109	48,849
Total non-current assets	228,037	216,166
Total assets	381,191	351,002
Current liabilities:
Accounts payable	74,362	54,763
Other current liabilities	49,167	47,493
Deferred revenue	7,876	7,612
Commercial paper	5,000	6,000
Term debt	11,169	9,613
Total current liabilities	147,574	125,481
Non-current liabilities:
Term debt	106,629	109,106
Other non-current liabilities	55,056	53,325
Total non-current liabilities	161,685	162,431
Total liabilities	309,259	287,912
Commitments and contingencies
Shareholders’ equity:
Common stock and additional paid-in capital, $0.00001 par value: 50,400,000 shares authorized; 16,340,851 and 16,426,786 shares issued and outstanding, respectively	58,424	57,365
Retained earnings	14,435	5,562
Accumulated other comprehensive income/(loss)	(927)	163
Total shareholders’ equity	71,932	63,090
Total liabilities and shareholders’ equity	$ 381,191	$ 351,002

CONDENSED CONSOLIDATED BALANC_2

CONDENSED CONSOLIDATED BALANCE SHEETS (Unaudited) (Parenthetical) - $ / shares	Dec. 25, 2021	Sep. 25, 2021
Statement of Financial Position [Abstract]
Common stock, par value (in dollars per share)	$ 0.00001	$ 0.00001
Common stock, shares authorized (in shares)	50,400,000,000	50,400,000,000
Common stock, shares issued (in shares)	16,340,851,000	16,426,786,000
Common stock, shares outstanding (in shares)	16,340,851,000	16,426,786,000

CONDENSED CONSOLIDATED STATEM_3

CONDENSED CONSOLIDATED STATEMENTS OF SHAREHOLDERS' EQUITY (Unaudited) - USD ($) $ in Millions	Total	Common stock and additional paid-in capital	Retained earnings	Accumulated other comprehensive income/(loss)
Beginning balances at Sep. 26, 2020	$ 65,339	$ 50,779	$ 14,966	$ (406)
Increase (Decrease) in Stockholders' Equity [Roll Forward]
Common stock withheld related to net share settlement of equity awards		(1,101)	(1,873)
Share-based compensation		2,066
Net income	28,755		28,755
Dividends and dividend equivalents declared			(3,547)
Common stock repurchased			(24,000)
Other comprehensive income/(loss)	585			585
Ending balances at Dec. 26, 2020	$ 66,224	51,744	14,301	179
Increase (Decrease) in Stockholders' Equity [Roll Forward]
Dividends and dividend equivalents declared per share or RSU (in dollars per share or RSU)	$ 0.205
Beginning balances at Sep. 25, 2021	$ 63,090	57,365	5,562	163
Increase (Decrease) in Stockholders' Equity [Roll Forward]
Common stock withheld related to net share settlement of equity awards		(1,263)	(1,730)
Share-based compensation		2,322
Net income	34,630		34,630
Dividends and dividend equivalents declared			(3,665)
Common stock repurchased	(20,400)		(20,362)
Other comprehensive income/(loss)	(1,090)			(1,090)
Ending balances at Dec. 25, 2021	$ 71,932	$ 58,424	$ 14,435	$ (927)
Increase (Decrease) in Stockholders' Equity [Roll Forward]
Dividends and dividend equivalents declared per share or RSU (in dollars per share or RSU)	$ 0.22

CONDENSED CONSOLIDATED STATEM_4

CONDENSED CONSOLIDATED STATEMENTS OF CASH FLOWS (Unaudited) - USD ($) $ in Millions	3 Months Ended
	Dec. 25, 2021	Dec. 26, 2020
Statement of Cash Flows [Abstract]
Cash, cash equivalents and restricted cash, beginning balances	$ 35,929	$ 39,789
Operating activities:
Net income	34,630	28,755
Adjustments to reconcile net income to cash generated by operating activities:
Depreciation and amortization	2,697	2,666
Share-based compensation expense	2,265	2,020
Deferred income tax expense/(benefit)	682	(58)
Other	167	25
Changes in operating assets and liabilities:
Accounts receivable, net	(3,934)	(10,945)
Inventories	681	(950)
Vendor non-trade receivables	(9,812)	(10,194)
Other current and non-current assets	(4,921)	(3,526)
Accounts payable	19,813	21,670
Deferred revenue	462	1,341
Other current and non-current liabilities	4,236	7,959
Cash generated by operating activities	46,966	38,763
Investing activities:
Purchases of marketable securities	(34,913)	(39,800)
Proceeds from maturities of marketable securities	11,309	25,177
Proceeds from sales of marketable securities	10,675	9,344
Payments for acquisition of property, plant and equipment	(2,803)	(3,500)
Other	(374)	195
Cash used in investing activities	(16,106)	(8,584)
Financing activities:
Payments for taxes related to net share settlement of equity awards	(2,888)	(2,861)
Payments for dividends and dividend equivalents	(3,732)	(3,613)
Repurchases of common stock	(20,478)	(24,775)
Repayments of term debt	0	(1,000)
Proceeds from/(Repayments of) commercial paper, net	(1,000)	22
Other	(61)	(22)
Cash used in financing activities	(28,159)	(32,249)
Increase/(Decrease) in cash, cash equivalents and restricted cash	2,701	(2,070)
Cash, cash equivalents and restricted cash, ending balances	38,630	37,719
Supplemental cash flow disclosure:
Cash paid for income taxes, net	5,235	1,787
Cash paid for interest	$ 531	$ 619

Summary of Significant Accounti

Summary of Significant Accounting Policies	3 Months Ended
Summary of Significant Accounting Policies	Dec. 25, 2021
Accounting Policies [Abstract]
Summary of Significant Accounting Policies	Summary of Significant Accounting Policies Basis of Presentation and Preparation The condensed consolidated financial statements include the accounts of Apple Inc. and its wholly owned subsidiaries (collectively “Apple” or the “Company”). Intercompany accounts and transactions have been eliminated. In the opinion of the Company’s management, the condensed consolidated financial statements reflect all adjustments, which are normal and recurring in nature, necessary for fair financial statement presentation. The preparation of these condensed consolidated financial statements and accompanying notes in conformity with U.S. generally accepted accounting principles requires management to make estimates and assumptions that affect the amounts reported. Actual results could differ materially from those estimates. Certain prior period amounts in the condensed consolidated financial statements and accompanying notes have been reclassified to conform to the current period’s presentation. These condensed consolidated financial statements and accompanying notes should be read in conjunction with the Company’s annual consolidated financial statements and accompanying notes included in its Annual Report on Form 10-K for the fiscal year ended September 25, 2021 (the “2021 Form 10-K”). The Company’s fiscal year is the 52- or 53-week period that ends on the last Saturday of September. An additional week is included in the first fiscal quarter every five or six years to realign the Company’s fiscal quarters with calendar quarters. The Company’s fiscal years 2022 and 2021 span 52 weeks each. Unless otherwise stated, references to particular years, quarters, months and periods refer to the Company’s fiscal years ended in September and the associated quarters, months and periods of those fiscal years. Earnings Per Share The following table shows the computation of basic and diluted earnings per share for the three months ended December 25, 2021 and December 26, 2020 (net income in millions and shares in thousands): Three Months Ended December 25, December 26, Numerator: Net income $ 34,630 $ 28,755 Denominator: Weighted-average basic shares outstanding 16,391,724 16,935,119 Effect of dilutive securities 127,567 178,569 Weighted-average diluted shares 16,519,291 17,113,688 Basic earnings per share $ 2.11 $ 1.70 Diluted earnings per share $ 2.10 $ 1.68

Revenue

Revenue	3 Months Ended
Revenue	Dec. 25, 2021
Revenue from Contract with Customer [Abstract]
Revenue	Revenue Net sales disaggregated by significant products and services for the three months ended December 25, 2021 and December 26, 2020 were as follows (in millions): Three Months Ended December 25, December 26, iPhone ® (1) $ 71,628 $ 65,597 Mac ® (1) 10,852 8,675 iPad ® (1) 7,248 8,435 Wearables, Home and Accessories (1)(2) 14,701 12,971 Services (3) 19,516 15,761 Total net sales (4) $ 123,945 $ 111,439 (1) Products net sales include amortization of the deferred value of unspecified software upgrade rights, which are bundled in the sales price of the respective product. (2) Wearables, Home and Accessories net sales include sales of AirPods ® , Apple TV ® , Apple Watch ® , Beats ® products, HomePod mini ® , iPod touch ® and accessories. (3) Services net sales include sales from the Company’s advertising, AppleCare ® , cloud, digital content, payment and other services. Services net sales also include amortization of the deferred value of services bundled in the sales price of certain products. (4) Includes $3.0 billion of revenue recognized in the three months ended December 25, 2021 that was included in deferred revenue as of September 25, 2021 and $2.5 billion of revenue recognized in the three months ended December 26, 2020 that was included in deferred revenue as of September 26, 2020. The Company’s proportion of net sales by disaggregated revenue source was generally consistent for each reportable segment in Note 9, “Segment Information and Geographic Data” for the three months ended December 25, 2021 and December 26, 2020, except in Greater China, where iPhone revenue represented a moderately higher proportion of net sales. As of December 25, 2021 and September 25, 2021, the Company had total deferred revenue of $12.4 billion and $11.9 billion, respectively. As of December 25, 2021, the Company expects 64% of total deferred revenue to be realized in less than a year, 27% within one-to-two years, 8% within two-to-three years and 1% in greater than three years.

Financial Instruments

Financial Instruments	3 Months Ended
Financial Instruments	Dec. 25, 2021
Investments, All Other Investments [Abstract]
Financial Instruments	Financial Instruments Cash, Cash Equivalents and Marketable Securities The following tables show the Company’s cash, cash equivalents and marketable securities by significant investment category as of December 25, 2021 and September 25, 2021 (in millions): December 25, 2021 Adjusted Unrealized Unrealized Fair Cash and Current Non-Current Marketable Cash $ 17,992 $ — $ — $ 17,992 $ 17,992 $ — $ — Level 1 (1) : Money market funds 11,356 — — 11,356 11,356 — — Mutual funds 215 16 (2) 229 — 229 — Subtotal 11,571 16 (2) 11,585 11,356 229 — Level 2 (2) : Equity securities 1,527 — (850) 677 — 677 — U.S. Treasury securities 29,221 64 (171) 29,114 3,247 5,775 20,092 U.S. agency securities 7,934 1 (116) 7,819 1,066 1,581 5,172 Non-U.S. government securities 18,983 160 (177) 18,966 200 3,279 15,487 Certificates of deposit and time deposits 3,648 — — 3,648 2,527 1,121 — Commercial paper 2,261 — — 2,261 702 1,559 — Corporate debt securities 88,617 718 (754) 88,581 29 11,665 76,887 Municipal securities 993 10 (1) 1,002 — 150 852 Mortgage- and asset-backed securities 21,072 102 (223) 20,951 — 758 20,193 Subtotal 174,256 1,055 (2,292) 173,019 7,771 26,565 138,683 Total (3) $ 203,819 $ 1,071 $ (2,294) $ 202,596 $ 37,119 $ 26,794 $ 138,683 September 25, 2021 Adjusted Unrealized Unrealized Fair Cash and Current Non-Current Cash $ 17,305 $ — $ — $ 17,305 $ 17,305 $ — $ — Level 1 (1) : Money market funds 9,608 — — 9,608 9,608 — — Mutual funds 175 11 (1) 185 — 185 — Subtotal 9,783 11 (1) 9,793 9,608 185 — Level 2 (2) : Equity securities 1,527 — (564) 963 — 963 — U.S. Treasury securities 22,878 102 (77) 22,903 3,596 6,625 12,682 U.S. agency securities 8,949 2 (64) 8,887 1,775 1,930 5,182 Non-U.S. government securities 20,201 211 (101) 20,311 390 3,091 16,830 Certificates of deposit and time deposits 1,300 — — 1,300 490 810 — Commercial paper 2,639 — — 2,639 1,776 863 — Corporate debt securities 83,883 1,242 (267) 84,858 — 12,327 72,531 Municipal securities 967 14 — 981 — 130 851 Mortgage- and asset-backed securities 20,529 171 (124) 20,576 — 775 19,801 Subtotal 162,873 1,742 (1,197) 163,418 8,027 27,514 127,877 Total (3) $ 189,961 $ 1,753 $ (1,198) $ 190,516 $ 34,940 $ 27,699 $ 127,877 (1) Level 1 fair value estimates are based on quoted prices in active markets for identical assets or liabilities. (2) Level 2 fair value estimates are based on observable inputs other than quoted prices in active markets for identical assets and liabilities, quoted prices for identical or similar assets or liabilities in inactive markets, or other inputs that are observable or can be corroborated by observable market data for substantially the full term of the assets or liabilities. (3) As of December 25, 2021 and September 25, 2021, total marketable securities included $16.8 billion and $17.9 billion, respectively, that was restricted from general use, related to the European Commission decision finding that Ireland granted state aid to the Company, and other agreements. The following table shows the fair value of the Company’s non-current marketable debt securities, by contractual maturity, as of December 25, 2021 (in millions): Due after 1 year through 5 years $ 93,206 Due after 5 years through 10 years 25,183 Due after 10 years 20,294 Total fair value $ 138,683 Derivative Instruments and Hedging The Company may use derivative instruments to partially offset its business exposure to foreign exchange and interest rate risk. However, the Company may choose not to hedge certain exposures for a variety of reasons, including accounting considerations or the prohibitive economic cost of hedging particular exposures. There can be no assurance the hedges will offset more than a portion of the financial impact resulting from movements in foreign exchange or interest rates. Foreign Exchange Risk To protect gross margins from fluctuations in foreign currency exchange rates, the Company may enter into forward contracts, option contracts or other instruments, and may designate these instruments as cash flow hedges. The Company generally hedges portions of its forecasted foreign currency exposure associated with revenue and inventory purchases, typically for up to 12 months. To protect the Company’s foreign currency–denominated term debt or marketable securities from fluctuations in foreign currency exchange rates, the Company may enter into forward contracts, cross-currency swaps or other instruments. The Company designates these instruments as either cash flow or fair value hedges. As of December 25, 2021, the Company’s hedged term debt– and marketable securities–related foreign currency transactions are expected to be recognized within 21 years. The Company may also enter into derivative instruments that are not designated as accounting hedges to protect gross margins from certain fluctuations in foreign currency exchange rates, as well as to offset a portion of the foreign currency exchange gains and losses generated by the remeasurement of certain assets and liabilities denominated in non-functional currencies. Interest Rate Risk To protect the Company’s term debt or marketable securities from fluctuations in interest rates, the Company may enter into interest rate swaps, options or other instruments. The Company designates these instruments as either cash flow or fair value hedges. The notional amounts of the Company’s outstanding derivative instruments as of December 25, 2021 and September 25, 2021 were as follows (in millions): December 25, 2021 September 25, 2021 Derivative instruments designated as accounting hedges: Foreign exchange contracts $ 77,009 $ 76,475 Interest rate contracts $ 16,875 $ 16,875 Derivative instruments not designated as accounting hedges: Foreign exchange contracts $ 176,268 $ 126,918 The gross fair values of the Company’s derivative assets and liabilities were not material as of December 25, 2021 and September 25, 2021. The gains and losses recognized in other comprehensive income and amounts reclassified from accumulated other comprehensive income to net income for the Company’s derivative instruments designated as cash flow hedges were not material in the three months ended December 25, 2021 and December 26, 2020. The carrying amounts of the Company’s hedged items in fair value hedges as of December 25, 2021 and September 25, 2021 were as follows (in millions): December 25, 2021 September 25, 2021 Hedged assets/(liabilities): Current and non-current marketable securities $ 15,322 $ 15,954 Current and non-current term debt $ (17,444) $ (17,857) The gains and losses on the Company’s derivative instruments designated as fair value hedges and the related hedged item adjustments were not material in the three months ended December 25, 2021 and December 26, 2020. Accounts Receivable Trade Receivables The Company has considerable trade receivables outstanding with its third-party cellular network carriers, wholesalers, retailers, resellers, small and mid-sized businesses and education, enterprise and government customers. The Company generally does not require collateral from its customers; however, the Company will require collateral or third-party credit support in certain instances to limit credit risk. In addition, when possible, the Company attempts to limit credit risk on trade receivables with credit insurance for certain customers or by requiring third-party financing, loans or leases to support credit exposure. These credit-financing arrangements are directly between the third-party financing company and the end customer. As such, the Company generally does not assume any recourse or credit risk sharing related to any of these arrangements. The Company’s cellular network carriers accounted for 45% and 42% of total trade receivables as of December 25, 2021 and September 25, 2021, respectively. Vendor Non-Trade Receivables The Company has non-trade receivables from certain of its manufacturing vendors resulting from the sale of components to these vendors who manufacture subassemblies or assemble final products for the Company. The Company purchases these components directly from suppliers. As of December 25, 2021, the Company had three vendors that individually represented 10% or more of total vendor non-trade receivables, which accounted for 54%, 13% and 12%. As of September 25, 2021, the Company had three vendors that individually represented 10% or more of total vendor non-trade receivables, which accounted for 52%, 11% and 11%.

Condensed Consolidated Financia

Condensed Consolidated Financial Statement Details	3 Months Ended
Condensed Consolidated Financial Statement Details	Dec. 25, 2021
Organization, Consolidation and Presentation of Financial Statements [Abstract]
Condensed Consolidated Financial Statement Details	Condensed Consolidated Financial Statement Details The following tables show the Company’s condensed consolidated financial statement details as of December 25, 2021 and September 25, 2021 (in millions): Property, Plant and Equipment, Net December 25, September 25, Gross property, plant and equipment $ 107,699 $ 109,723 Accumulated depreciation and amortization (68,454) (70,283) Total property, plant and equipment, net $ 39,245 $ 39,440 Other Non-Current Liabilities December 25, September 25, Long-term taxes payable $ 24,689 $ 24,689 Other non-current liabilities 30,367 28,636 Total other non-current liabilities $ 55,056 $ 53,325 Other Income/(Expense), Net The following table shows the detail of other income/(expense), net for the three months ended December 25, 2021 and December 26, 2020 (in millions): Three Months Ended December 25, December 26, Interest and dividend income $ 650 $ 747 Interest expense (694) (638) Other expense, net (203) (64) Total other income/(expense), net $ (247) $ 45

Debt

Debt	3 Months Ended
Debt	Dec. 25, 2021
Debt Disclosure [Abstract]
Debt	Debt Commercial Paper The Company issues unsecured short-term promissory notes (“Commercial Paper”) pursuant to a commercial paper program. The Company uses net proceeds from the commercial paper program for general corporate purposes, including dividends and share repurchases. As of December 25, 2021 and September 25, 2021, the Company had $5.0 billion and $6.0 billion of Commercial Paper outstanding, respectively. The following table provides a summary of cash flows associated with the issuance and maturities of Commercial Paper for the three months ended December 25, 2021 and December 26, 2020 (in millions): Three Months Ended December 25, December 26, Maturities 90 days or less: Proceeds from commercial paper, net $ 1,339 $ 1,439 Maturities greater than 90 days: Proceeds from commercial paper 1,191 780 Repayments of commercial paper (3,530) (2,197) Repayments of commercial paper, net (2,339) (1,417) Total proceeds from/(repayments of) commercial paper, net $ (1,000) $ 22 Term Debt As of December 25, 2021 and September 25, 2021, the Company had outstanding floating- and fixed-rate notes with varying maturities for an aggregate carrying amount of $117.8 billion and $118.7 billion, respectively (collectively the “Notes”). As of December 25, 2021 and September 25, 2021, the fair value of the Company’s Notes, based on Level 2 inputs, was $123.5 billion and $125.3 billion, respectively.

Shareholders' Equity

Shareholders' Equity	3 Months Ended
Shareholders' Equity	Dec. 25, 2021
Equity [Abstract]
Shareholders' Equity	Shareholders’ Equity Share Repurchase Program As of December 25, 2021, the Company was authorized to purchase up to $315 billion of the Company’s common stock under a share repurchase program (the “Program”). During the three months ended December 25, 2021, the Company repurchased 124 million shares of its common stock for $20.4 billion, including 30 million shares initially delivered under accelerated share repurchase agreements (“ASRs”) entered into in November 2021, bringing the total utilization under the Program to $274.5 billion as of December 25, 2021. The Program does not obligate the Company to acquire any specific number of shares. Under the Program, shares may be repurchased in privately negotiated and/or open market transactions, including under plans complying with Rule 10b5-1 under the Securities Exchange Act of 1934, as amended.

Benefit Plans

Benefit Plans	3 Months Ended
Benefit Plans	Dec. 25, 2021
Share-based Payment Arrangement [Abstract]
Benefit Plans	Benefit Plans Restricted Stock Units A summary of the Company’s restricted stock unit (“RSU”) activity and related information for the three months ended December 25, 2021 is as follows: Number of RSUs (in thousands) Weighted-Average Aggregate Fair Value (in millions) Balance as of September 25, 2021 240,427 $ 75.16 RSUs granted 67,645 $ 147.33 RSUs vested (56,649) $ 61.75 RSUs canceled (4,886) $ 93.21 Balance as of December 25, 2021 246,537 $ 97.69 $ 43,460 The fair value as of the respective vesting dates of RSUs was $8.5 billion for the three months ended both December 25, 2021 and December 26, 2020. Share-Based Compensation The following table shows share-based compensation expense and the related income tax benefit included in the Condensed Consolidated Statements of Operations for the three months ended December 25, 2021 and December 26, 2020 (in millions): Three Months Ended December 25, December 26, Share-based compensation expense $ 2,265 $ 2,020 Income tax benefit related to share-based compensation expense $ (1,536) $ (1,624) As of December 25, 2021, the total unrecognized compensation cost related to outstanding RSUs and stock options was $20.6 billion, which the Company expects to recognize over a weighted-average period of 3.0 years.

Commitments and Contingencies

Commitments and Contingencies	3 Months Ended
Commitments and Contingencies	Dec. 25, 2021
Commitments and Contingencies Disclosure [Abstract]
Commitments and Contingencies	Commitments and Contingencies Accrued Warranty The following table shows changes in the Company’s accrued warranties and related costs for the three months ended December 25, 2021 and December 26, 2020 (in millions): Three Months Ended December 25, December 26, Beginning accrued warranty and related costs $ 3,364 $ 3,354 Cost of warranty claims (672) (723) Accruals for product warranty 838 1,493 Ending accrued warranty and related costs $ 3,530 $ 4,124 Contingencies The Company is subject to various legal proceedings and claims that have arisen in the ordinary course of business and that have not been fully resolved. The outcome of litigation is inherently uncertain. In the opinion of management, there was not at least a reasonable possibility the Company may have incurred a material loss, or a material loss greater than a recorded accrual, concerning loss contingencies for asserted legal and other claims.

Segment Information and Geograp

Segment Information and Geographic Data	3 Months Ended
Segment Information and Geographic Data	Dec. 25, 2021
Segment Reporting [Abstract]
Segment Information and Geographic Data	Segment Information and Geographic Data The following table shows information by reportable segment for the three months ended December 25, 2021 and December 26, 2020 (in millions): Three Months Ended December 25, December 26, Americas: Net sales $ 51,496 $ 46,310 Operating income $ 19,585 $ 15,785 Europe: Net sales $ 29,749 $ 27,306 Operating income $ 11,545 $ 9,589 Greater China: Net sales $ 25,783 $ 21,313 Operating income $ 11,183 $ 8,530 Japan: Net sales $ 7,107 $ 8,285 Operating income $ 3,349 $ 3,503 Rest of Asia Pacific: Net sales $ 9,810 $ 8,225 Operating income $ 3,995 $ 2,953 A reconciliation of the Company’s segment operating income to the Condensed Consolidated Statements of Operations for the three months ended December 25, 2021 and December 26, 2020 is as follows (in millions): Three Months Ended December 25, December 26, Segment operating income $ 49,657 $ 40,360 Research and development expense (6,306) (5,163) Other corporate expenses, net (1,863) (1,663) Total operating income $ 41,488 $ 33,534

Summary of Significant Accoun_2

Summary of Significant Accounting Policies (Policies)	3 Months Ended
Summary of Significant Accounting Policies (Policies)	Dec. 25, 2021
Accounting Policies [Abstract]
Basis of Presentation and Preparation	Basis of Presentation and Preparation The condensed consolidated financial statements include the accounts of Apple Inc. and its wholly owned subsidiaries (collectively “Apple” or the “Company”). Intercompany accounts and transactions have been eliminated. In the opinion of the Company’s management, the condensed consolidated financial statements reflect all adjustments, which are normal and recurring in nature, necessary for fair financial statement presentation. The preparation of these condensed consolidated financial statements and accompanying notes in conformity with U.S. generally accepted accounting principles requires management to make estimates and assumptions that affect the amounts reported. Actual results could differ materially from those estimates. Certain prior period amounts in the condensed consolidated financial statements and accompanying notes have been reclassified to conform to the current period’s presentation. These condensed consolidated financial statements and accompanying notes should be read in conjunction with the Company’s annual consolidated financial statements and accompanying notes included in its Annual Report on Form 10-K for the fiscal year ended September 25, 2021 (the “2021 Form 10-K”).
Fiscal Period	The Company’s fiscal year is the 52- or 53-week period that ends on the last Saturday of September. An additional week is included in the first fiscal quarter every five or six years to realign the Company’s fiscal quarters with calendar quarters. The Company’s fiscal years 2022 and 2021 span 52 weeks each. Unless otherwise stated, references to particular years, quarters, months and periods refer to the Company’s fiscal years ended in September and the associated quarters, months and periods of those fiscal years.
Fair Value Measurements	Level 1 fair value estimates are based on quoted prices in active markets for identical assets or liabilities.Level 2 fair value estimates are based on observable inputs other than quoted prices in active markets for identical assets and liabilities, quoted prices for identical or similar assets or liabilities in inactive markets, or other inputs that are observable or can be corroborated by observable market data for substantially the full term of the assets or liabilities.

Summary of Significant Accoun_3

Summary of Significant Accounting Policies (Tables)	3 Months Ended
Summary of Significant Accounting Policies (Tables)	Dec. 25, 2021
Accounting Policies [Abstract]
Computation of Basic and Diluted Earnings Per Share	The following table shows the computation of basic and diluted earnings per share for the three months ended December 25, 2021 and December 26, 2020 (net income in millions and shares in thousands): Three Months Ended December 25, December 26, Numerator: Net income $ 34,630 $ 28,755 Denominator: Weighted-average basic shares outstanding 16,391,724 16,935,119 Effect of dilutive securities 127,567 178,569 Weighted-average diluted shares 16,519,291 17,113,688 Basic earnings per share $ 2.11 $ 1.70 Diluted earnings per share $ 2.10 $ 1.68

Revenue (Tables)

Revenue (Tables)	3 Months Ended
Revenue (Tables)	Dec. 25, 2021
Revenue from Contract with Customer [Abstract]
Net Sales Disaggregated by Significant Products and Services	Net sales disaggregated by significant products and services for the three months ended December 25, 2021 and December 26, 2020 were as follows (in millions): Three Months Ended December 25, December 26, iPhone ® (1) $ 71,628 $ 65,597 Mac ® (1) 10,852 8,675 iPad ® (1) 7,248 8,435 Wearables, Home and Accessories (1)(2) 14,701 12,971 Services (3) 19,516 15,761 Total net sales (4) $ 123,945 $ 111,439 (1) Products net sales include amortization of the deferred value of unspecified software upgrade rights, which are bundled in the sales price of the respective product. (2) Wearables, Home and Accessories net sales include sales of AirPods ® , Apple TV ® , Apple Watch ® , Beats ® products, HomePod mini ® , iPod touch ® and accessories. (3) Services net sales include sales from the Company’s advertising, AppleCare ® , cloud, digital content, payment and other services. Services net sales also include amortization of the deferred value of services bundled in the sales price of certain products. (4) Includes $3.0 billion of revenue recognized in the three months ended December 25, 2021 that was included in deferred revenue as of September 25, 2021 and $2.5 billion of revenue recognized in the three months ended December 26, 2020 that was included in deferred revenue as of September 26, 2020.

Financial Instruments (Tables)

Financial Instruments (Tables)	3 Months Ended
Financial Instruments (Tables)	Dec. 25, 2021
Investments, All Other Investments [Abstract]
Cash, Cash Equivalents and Marketable Securities by Significant Investment Category	The following tables show the Company’s cash, cash equivalents and marketable securities by significant investment category as of December 25, 2021 and September 25, 2021 (in millions): December 25, 2021 Adjusted Unrealized Unrealized Fair Cash and Current Non-Current Marketable Cash $ 17,992 $ — $ — $ 17,992 $ 17,992 $ — $ — Level 1 (1) : Money market funds 11,356 — — 11,356 11,356 — — Mutual funds 215 16 (2) 229 — 229 — Subtotal 11,571 16 (2) 11,585 11,356 229 — Level 2 (2) : Equity securities 1,527 — (850) 677 — 677 — U.S. Treasury securities 29,221 64 (171) 29,114 3,247 5,775 20,092 U.S. agency securities 7,934 1 (116) 7,819 1,066 1,581 5,172 Non-U.S. government securities 18,983 160 (177) 18,966 200 3,279 15,487 Certificates of deposit and time deposits 3,648 — — 3,648 2,527 1,121 — Commercial paper 2,261 — — 2,261 702 1,559 — Corporate debt securities 88,617 718 (754) 88,581 29 11,665 76,887 Municipal securities 993 10 (1) 1,002 — 150 852 Mortgage- and asset-backed securities 21,072 102 (223) 20,951 — 758 20,193 Subtotal 174,256 1,055 (2,292) 173,019 7,771 26,565 138,683 Total (3) $ 203,819 $ 1,071 $ (2,294) $ 202,596 $ 37,119 $ 26,794 $ 138,683 September 25, 2021 Adjusted Unrealized Unrealized Fair Cash and Current Non-Current Cash $ 17,305 $ — $ — $ 17,305 $ 17,305 $ — $ — Level 1 (1) : Money market funds 9,608 — — 9,608 9,608 — — Mutual funds 175 11 (1) 185 — 185 — Subtotal 9,783 11 (1) 9,793 9,608 185 — Level 2 (2) : Equity securities 1,527 — (564) 963 — 963 — U.S. Treasury securities 22,878 102 (77) 22,903 3,596 6,625 12,682 U.S. agency securities 8,949 2 (64) 8,887 1,775 1,930 5,182 Non-U.S. government securities 20,201 211 (101) 20,311 390 3,091 16,830 Certificates of deposit and time deposits 1,300 — — 1,300 490 810 — Commercial paper 2,639 — — 2,639 1,776 863 — Corporate debt securities 83,883 1,242 (267) 84,858 — 12,327 72,531 Municipal securities 967 14 — 981 — 130 851 Mortgage- and asset-backed securities 20,529 171 (124) 20,576 — 775 19,801 Subtotal 162,873 1,742 (1,197) 163,418 8,027 27,514 127,877 Total (3) $ 189,961 $ 1,753 $ (1,198) $ 190,516 $ 34,940 $ 27,699 $ 127,877 (1) Level 1 fair value estimates are based on quoted prices in active markets for identical assets or liabilities. (2) Level 2 fair value estimates are based on observable inputs other than quoted prices in active markets for identical assets and liabilities, quoted prices for identical or similar assets or liabilities in inactive markets, or other inputs that are observable or can be corroborated by observable market data for substantially the full term of the assets or liabilities. (3) As of December 25, 2021 and September 25, 2021, total marketable securities included $16.8 billion and $17.9 billion, respectively, that was restricted from general use, related to the European Commission decision finding that Ireland granted state aid to the Company, and other agreements.
Non-Current Marketable Debt Securities by Contractual Maturity	The following table shows the fair value of the Company’s non-current marketable debt securities, by contractual maturity, as of December 25, 2021 (in millions): Due after 1 year through 5 years $ 93,206 Due after 5 years through 10 years 25,183 Due after 10 years 20,294 Total fair value $ 138,683
Notional Amounts of Outstanding Derivative Instruments	The notional amounts of the Company’s outstanding derivative instruments as of December 25, 2021 and September 25, 2021 were as follows (in millions): December 25, 2021 September 25, 2021 Derivative instruments designated as accounting hedges: Foreign exchange contracts $ 77,009 $ 76,475 Interest rate contracts $ 16,875 $ 16,875 Derivative instruments not designated as accounting hedges: Foreign exchange contracts $ 176,268 $ 126,918
Carrying Amounts of Hedged Items in Fair Value Hedges	The carrying amounts of the Company’s hedged items in fair value hedges as of December 25, 2021 and September 25, 2021 were as follows (in millions): December 25, 2021 September 25, 2021 Hedged assets/(liabilities): Current and non-current marketable securities $ 15,322 $ 15,954 Current and non-current term debt $ (17,444) $ (17,857)

Condensed Consolidated Financ_2

Condensed Consolidated Financial Statement Details (Tables)	3 Months Ended
Condensed Consolidated Financial Statement Details (Tables)	Dec. 25, 2021
Organization, Consolidation and Presentation of Financial Statements [Abstract]
Property, Plant and Equipment, Net	Property, Plant and Equipment, Net December 25, September 25, Gross property, plant and equipment $ 107,699 $ 109,723 Accumulated depreciation and amortization (68,454) (70,283) Total property, plant and equipment, net $ 39,245 $ 39,440
Other Non-Current Liabilities	Other Non-Current Liabilities December 25, September 25, Long-term taxes payable $ 24,689 $ 24,689 Other non-current liabilities 30,367 28,636 Total other non-current liabilities $ 55,056 $ 53,325
Other Income/(Expense), Net	Other Income/(Expense), Net The following table shows the detail of other income/(expense), net for the three months ended December 25, 2021 and December 26, 2020 (in millions): Three Months Ended December 25, December 26, Interest and dividend income $ 650 $ 747 Interest expense (694) (638) Other expense, net (203) (64) Total other income/(expense), net $ (247) $ 45

Debt (Tables)

Debt (Tables)	3 Months Ended
Debt (Tables)	Dec. 25, 2021
Debt Disclosure [Abstract]
Summary of Cash Flows Associated with Issuance and Maturities of Commercial Paper	The following table provides a summary of cash flows associated with the issuance and maturities of Commercial Paper for the three months ended December 25, 2021 and December 26, 2020 (in millions): Three Months Ended December 25, December 26, Maturities 90 days or less: Proceeds from commercial paper, net $ 1,339 $ 1,439 Maturities greater than 90 days: Proceeds from commercial paper 1,191 780 Repayments of commercial paper (3,530) (2,197) Repayments of commercial paper, net (2,339) (1,417) Total proceeds from/(repayments of) commercial paper, net $ (1,000) $ 22

Benefit Plans (Tables)

Benefit Plans (Tables)	3 Months Ended
Benefit Plans (Tables)	Dec. 25, 2021
Share-based Payment Arrangement [Abstract]
Restricted Stock Unit Activity	A summary of the Company’s restricted stock unit (“RSU”) activity and related information for the three months ended December 25, 2021 is as follows: Number of RSUs (in thousands) Weighted-Average Aggregate Fair Value (in millions) Balance as of September 25, 2021 240,427 $ 75.16 RSUs granted 67,645 $ 147.33 RSUs vested (56,649) $ 61.75 RSUs canceled (4,886) $ 93.21 Balance as of December 25, 2021 246,537 $ 97.69 $ 43,460
Summary of Share-Based Compensation Expense and the Related Income Tax Benefit	The following table shows share-based compensation expense and the related income tax benefit included in the Condensed Consolidated Statements of Operations for the three months ended December 25, 2021 and December 26, 2020 (in millions): Three Months Ended December 25, December 26, Share-based compensation expense $ 2,265 $ 2,020 Income tax benefit related to share-based compensation expense $ (1,536) $ (1,624)

Commitments and Contingencies (

Commitments and Contingencies (Tables)	3 Months Ended
Commitments and Contingencies (Tables)	Dec. 25, 2021
Commitments and Contingencies Disclosure [Abstract]
Changes in Accrued Warranties and Related Costs	The following table shows changes in the Company’s accrued warranties and related costs for the three months ended December 25, 2021 and December 26, 2020 (in millions): Three Months Ended December 25, December 26, Beginning accrued warranty and related costs $ 3,364 $ 3,354 Cost of warranty claims (672) (723) Accruals for product warranty 838 1,493 Ending accrued warranty and related costs $ 3,530 $ 4,124

Segment Information and Geogr_2

Segment Information and Geographic Data (Tables)	3 Months Ended
Segment Information and Geographic Data (Tables)	Dec. 25, 2021
Segment Reporting [Abstract]
Information by Reportable Segment	The following table shows information by reportable segment for the three months ended December 25, 2021 and December 26, 2020 (in millions): Three Months Ended December 25, December 26, Americas: Net sales $ 51,496 $ 46,310 Operating income $ 19,585 $ 15,785 Europe: Net sales $ 29,749 $ 27,306 Operating income $ 11,545 $ 9,589 Greater China: Net sales $ 25,783 $ 21,313 Operating income $ 11,183 $ 8,530 Japan: Net sales $ 7,107 $ 8,285 Operating income $ 3,349 $ 3,503 Rest of Asia Pacific: Net sales $ 9,810 $ 8,225 Operating income $ 3,995 $ 2,953
Reconciliation of Segment Operating Income to the Condensed Consolidated Statements of Operations	A reconciliation of the Company’s segment operating income to the Condensed Consolidated Statements of Operations for the three months ended December 25, 2021 and December 26, 2020 is as follows (in millions): Three Months Ended December 25, December 26, Segment operating income $ 49,657 $ 40,360 Research and development expense (6,306) (5,163) Other corporate expenses, net (1,863) (1,663) Total operating income $ 41,488 $ 33,534

Summary of Significant Accoun_4

Summary of Significant Accounting Policies - Computation of Basic and Diluted Earnings Per Share (Details) - USD ($) $ / shares in Units, shares in Thousands, $ in Millions	3 Months Ended
	Dec. 25, 2021	Dec. 26, 2020
Numerator:
Net income	$ 34,630	$ 28,755
Denominator:
Weighted-average basic shares outstanding (in shares)	16,391,724	16,935,119
Effect of dilutive securities (in shares)	127,567	178,569
Weighted-average diluted shares (in shares)	16,519,291	17,113,688
Basic earnings per share (in dollars per share)	$ 2.11	$ 1.70
Diluted earnings per share (in dollars per share)	$ 2.10	$ 1.68

Revenue - Net Sales Disaggregat

Revenue - Net Sales Disaggregated by Significant Products and Services (Details) - USD ($) $ in Millions	3 Months Ended
	Dec. 25, 2021	Dec. 26, 2020
Disaggregation of Revenue [Line Items]
Net sales	$ 123,945	$ 111,439
Revenue recognized that was included in deferred revenue at the beginning of the period	3,000	2,500
iPhone
Disaggregation of Revenue [Line Items]
Net sales	71,628	65,597
Mac
Disaggregation of Revenue [Line Items]
Net sales	10,852	8,675
iPad
Disaggregation of Revenue [Line Items]
Net sales	7,248	8,435
Wearables, Home and Accessories
Disaggregation of Revenue [Line Items]
Net sales	14,701	12,971
Services
Disaggregation of Revenue [Line Items]
Net sales	$ 19,516	$ 15,761

Revenue - Additional Informatio

Revenue - Additional Information (Details) - USD ($) $ in Billions	Dec. 25, 2021	Sep. 25, 2021
Revenue from Contract with Customer [Abstract]
Total deferred revenue	$ 12.4	$ 11.9

Revenue - Deferred Revenue, Exp

Revenue - Deferred Revenue, Expected Timing of Realization (Details)	Dec. 25, 2021
Revenue, Remaining Performance Obligation, Expected Timing of Satisfaction, Start Date [Axis]: 2021-12-26
Revenue, Remaining Performance Obligation, Expected Timing of Satisfaction [Line Items]
Deferred revenue, expected timing of realization, percentage	64.00%
Deferred revenue, expected timing of realization, period	1 year
Revenue, Remaining Performance Obligation, Expected Timing of Satisfaction, Start Date [Axis]: 2023-01-01
Revenue, Remaining Performance Obligation, Expected Timing of Satisfaction [Line Items]
Deferred revenue, expected timing of realization, percentage	27.00%
Deferred revenue, expected timing of realization, period	1 year
Revenue, Remaining Performance Obligation, Expected Timing of Satisfaction, Start Date [Axis]: 2023-12-31
Revenue, Remaining Performance Obligation, Expected Timing of Satisfaction [Line Items]
Deferred revenue, expected timing of realization, percentage	8.00%
Deferred revenue, expected timing of realization, period	1 year
Revenue, Remaining Performance Obligation, Expected Timing of Satisfaction, Start Date [Axis]: 2024-12-29
Revenue, Remaining Performance Obligation, Expected Timing of Satisfaction [Line Items]
Deferred revenue, expected timing of realization, percentage	1.00%
Deferred revenue, expected timing of realization, period

Financial Instruments - Cash, C

Financial Instruments - Cash, Cash Equivalents and Marketable Securities (Details) - USD ($) $ in Millions	Dec. 25, 2021	Sep. 25, 2021
Debt Securities, Available-for-sale [Line Items]
Cash, Cash Equivalents and Marketable Securities, Adjusted Cost	$ 203,819	$ 189,961
Cash Equivalents and Marketable Securities, Unrealized Gains	1,071	1,753
Cash Equivalents and Marketable Securities, Unrealized Losses	2,294	1,198
Cash, Cash Equivalents and Marketable Securities, Fair Value	202,596	190,516
Cash and Cash Equivalents	37,119	34,940
Current Marketable Securities	26,794	27,699
Non-Current Marketable Securities	138,683	127,877
Total marketable securities that were restricted from general use	16,800	17,900
Level 1
Debt Securities, Available-for-sale [Line Items]
Marketable Securities, Equity, Adjusted Cost	11,571	9,783
Marketable Securities, Equity, Unrealized Gains	16	11
Marketable Securities, Equity, Unrealized Losses	(2)	(1)
Marketable Securities, Equity, Fair Value	11,585	9,793
Cash and Cash Equivalents	11,356	9,608
Current Marketable Securities	229	185
Non-Current Marketable Securities	0	0
Level 2
Debt Securities, Available-for-sale [Line Items]
Marketable Securities, Debt, Adjusted Cost	174,256	162,873
Marketable Securities, Debt, Unrealized Gains	1,055	1,742
Marketable Securities, Debt, Unrealized Losses	(2,292)	(1,197)
Marketable Securities, Debt, Fair Value	173,019	163,418
Cash and Cash Equivalents	7,771	8,027
Current Marketable Securities	26,565	27,514
Non-Current Marketable Securities	138,683	127,877
Cash
Debt Securities, Available-for-sale [Line Items]
Cash	17,992	17,305
Cash and Cash Equivalents	17,992	17,305
Current Marketable Securities	0	0
Non-Current Marketable Securities	0	0
Money market funds \| Level 1
Debt Securities, Available-for-sale [Line Items]
Marketable Securities, Equity, Adjusted Cost	11,356	9,608
Marketable Securities, Equity, Unrealized Gains	0	0
Marketable Securities, Equity, Unrealized Losses	0	0
Marketable Securities, Equity, Fair Value	11,356	9,608
Cash and Cash Equivalents	11,356	9,608
Current Marketable Securities	0	0
Non-Current Marketable Securities	0	0
Mutual funds \| Level 1
Debt Securities, Available-for-sale [Line Items]
Marketable Securities, Equity, Adjusted Cost	215	175
Marketable Securities, Equity, Unrealized Gains	16	11
Marketable Securities, Equity, Unrealized Losses	(2)	(1)
Marketable Securities, Equity, Fair Value	229	185
Cash and Cash Equivalents	0	0
Current Marketable Securities	229	185
Non-Current Marketable Securities	0	0
Equity securities \| Level 2
Debt Securities, Available-for-sale [Line Items]
Marketable Securities, Equity, Adjusted Cost	1,527	1,527
Marketable Securities, Equity, Unrealized Gains	0	0
Marketable Securities, Equity, Unrealized Losses	(850)	(564)
Marketable Securities, Equity, Fair Value	677	963
Cash and Cash Equivalents	0	0
Current Marketable Securities	677	963
Non-Current Marketable Securities	0	0
U.S. Treasury securities \| Level 2
Debt Securities, Available-for-sale [Line Items]
Marketable Securities, Debt, Adjusted Cost	29,221	22,878
Marketable Securities, Debt, Unrealized Gains	64	102
Marketable Securities, Debt, Unrealized Losses	(171)	(77)
Marketable Securities, Debt, Fair Value	29,114	22,903
Cash and Cash Equivalents	3,247	3,596
Current Marketable Securities	5,775	6,625
Non-Current Marketable Securities	20,092	12,682
U.S. agency securities \| Level 2
Debt Securities, Available-for-sale [Line Items]
Marketable Securities, Debt, Adjusted Cost	7,934	8,949
Marketable Securities, Debt, Unrealized Gains	1	2
Marketable Securities, Debt, Unrealized Losses	(116)	(64)
Marketable Securities, Debt, Fair Value	7,819	8,887
Cash and Cash Equivalents	1,066	1,775
Current Marketable Securities	1,581	1,930
Non-Current Marketable Securities	5,172	5,182
Non-U.S. government securities \| Level 2
Debt Securities, Available-for-sale [Line Items]
Marketable Securities, Debt, Adjusted Cost	18,983	20,201
Marketable Securities, Debt, Unrealized Gains	160	211
Marketable Securities, Debt, Unrealized Losses	(177)	(101)
Marketable Securities, Debt, Fair Value	18,966	20,311
Cash and Cash Equivalents	200	390
Current Marketable Securities	3,279	3,091
Non-Current Marketable Securities	15,487	16,830
Certificates of deposit and time deposits \| Level 2
Debt Securities, Available-for-sale [Line Items]
Marketable Securities, Debt, Adjusted Cost	3,648	1,300
Marketable Securities, Debt, Unrealized Gains	0	0
Marketable Securities, Debt, Unrealized Losses	0	0
Marketable Securities, Debt, Fair Value	3,648	1,300
Cash and Cash Equivalents	2,527	490
Current Marketable Securities	1,121	810
Non-Current Marketable Securities	0	0
Commercial paper \| Level 2
Debt Securities, Available-for-sale [Line Items]
Marketable Securities, Debt, Adjusted Cost	2,261	2,639
Marketable Securities, Debt, Unrealized Gains	0	0
Marketable Securities, Debt, Unrealized Losses	0	0
Marketable Securities, Debt, Fair Value	2,261	2,639
Cash and Cash Equivalents	702	1,776
Current Marketable Securities	1,559	863
Non-Current Marketable Securities	0	0
Corporate debt securities \| Level 2
Debt Securities, Available-for-sale [Line Items]
Marketable Securities, Debt, Adjusted Cost	88,617	83,883
Marketable Securities, Debt, Unrealized Gains	718	1,242
Marketable Securities, Debt, Unrealized Losses	(754)	(267)
Marketable Securities, Debt, Fair Value	88,581	84,858
Cash and Cash Equivalents	29	0
Current Marketable Securities	11,665	12,327
Non-Current Marketable Securities	76,887	72,531
Municipal securities \| Level 2
Debt Securities, Available-for-sale [Line Items]
Marketable Securities, Debt, Adjusted Cost	993	967
Marketable Securities, Debt, Unrealized Gains	10	14
Marketable Securities, Debt, Unrealized Losses	(1)	0
Marketable Securities, Debt, Fair Value	1,002	981
Cash and Cash Equivalents	0	0
Current Marketable Securities	150	130
Non-Current Marketable Securities	852	851
Mortgage- and asset-backed securities \| Level 2
Debt Securities, Available-for-sale [Line Items]
Marketable Securities, Debt, Adjusted Cost	21,072	20,529
Marketable Securities, Debt, Unrealized Gains	102	171
Marketable Securities, Debt, Unrealized Losses	(223)	(124)
Marketable Securities, Debt, Fair Value	20,951	20,576
Cash and Cash Equivalents	0	0
Current Marketable Securities	758	775
Non-Current Marketable Securities	$ 20,193	$ 19,801

Financial Instruments - Non-Cur

Financial Instruments - Non-Current Marketable Debt Securities by Contractual Maturity (Details) $ in Millions	Dec. 25, 2021USD ($)
Fair value of non-current marketable debt securities by contractual maturity
Due after 1 year through 5 years	$ 93,206
Due after 5 years through 10 years	25,183
Due after 10 years	20,294
Total fair value	$ 138,683

Financial Instruments - Additio

Financial Instruments - Additional Information (Details) - Vendor	3 Months Ended	12 Months Ended
	Dec. 25, 2021	Sep. 25, 2021
Trade receivables \| Credit concentration risk \| Cellular network carriers
Financial Instruments [Line Items]
Concentration risk, percentage	45.00%	42.00%
Non-trade receivables \| Credit concentration risk
Financial Instruments [Line Items]
Number of vendors that individually represented 10% or more of total vendor non-trade receivables	3	3
Non-trade receivables \| Credit concentration risk \| Vendor one
Financial Instruments [Line Items]
Concentration risk, percentage	54.00%	52.00%
Non-trade receivables \| Credit concentration risk \| Vendor two
Financial Instruments [Line Items]
Concentration risk, percentage	13.00%	11.00%
Non-trade receivables \| Credit concentration risk \| Vendor three
Financial Instruments [Line Items]
Concentration risk, percentage	12.00%	11.00%
Hedges of foreign currency exposure associated with revenue and inventory purchases
Financial Instruments [Line Items]
Hedged foreign currency transactions, expected recognition period	12 months
Hedges of foreign currency exposure associated with term debt and marketable securities
Financial Instruments [Line Items]
Hedged foreign currency transactions, expected recognition period	21 years

Financial Instruments - Notiona

Financial Instruments - Notional Amounts of Derivative Instruments (Details) - USD ($) $ in Millions	Dec. 25, 2021	Sep. 25, 2021
Derivative instruments designated as accounting hedges \| Foreign exchange contracts
Derivative [Line Items]
Derivatives, notional amount	$ 77,009	$ 76,475
Derivative instruments designated as accounting hedges \| Interest rate contracts
Derivative [Line Items]
Derivatives, notional amount	16,875	16,875
Derivatives instruments not designated as accounting hedges \| Foreign exchange contracts
Derivative [Line Items]
Derivatives, notional amount	$ 176,268	$ 126,918

Financial Instruments - Derivat

Financial Instruments - Derivative Instruments Designated as Fair Value Hedges and Related Hedged Items (Details) - USD ($) $ in Millions	Dec. 25, 2021	Sep. 25, 2021
Current and non-current marketable securities
Derivative Instruments and Hedging Activities Disclosures [Line Items]
Carrying amount of hedged marketable securities	$ 15,322	$ 15,954
Current and non-current term debt
Derivative Instruments and Hedging Activities Disclosures [Line Items]
Carrying amount of hedged term debt	$ (17,444)	$ (17,857)

Condensed Consolidated Financ_3

Condensed Consolidated Financial Statement Details - Property, Plant and Equipment, Net (Details) - USD ($) $ in Millions	Dec. 25, 2021	Sep. 25, 2021
Organization, Consolidation and Presentation of Financial Statements [Abstract]
Gross property, plant and equipment	$ 107,699	$ 109,723
Accumulated depreciation and amortization	(68,454)	(70,283)
Total property, plant and equipment, net	$ 39,245	$ 39,440

Condensed Consolidated Financ_4

Condensed Consolidated Financial Statement Details - Other Non-Current Liabilities (Details) - USD ($) $ in Millions	Dec. 25, 2021	Sep. 25, 2021
Organization, Consolidation and Presentation of Financial Statements [Abstract]
Long-term taxes payable	$ 24,689	$ 24,689
Other non-current liabilities	30,367	28,636
Total other non-current liabilities	$ 55,056	$ 53,325

Condensed Consolidated Financ_5

Condensed Consolidated Financial Statement Details - Other Income/(Expense), Net (Details) - USD ($) $ in Millions	3 Months Ended
	Dec. 25, 2021	Dec. 26, 2020
Organization, Consolidation and Presentation of Financial Statements [Abstract]
Interest and dividend income	$ 650	$ 747
Interest expense	(694)	(638)
Other expense, net	(203)	(64)
Total other income/(expense), net	$ (247)	$ 45

Debt - Additional Information (

Debt - Additional Information (Details) - USD ($) $ in Millions	Dec. 25, 2021	Sep. 25, 2021
Debt Instrument [Line Items]
Commercial paper	$ 5,000	$ 6,000
Floating- and fixed-rate notes, aggregate carrying amount	117,800	118,700
Commercial paper
Debt Instrument [Line Items]
Commercial paper	5,000	6,000
Level 2
Debt Instrument [Line Items]
Floating- and fixed-rate notes, aggregate fair value	$ 123,500	$ 125,300

Debt - Summary of Cash Flows As

Debt - Summary of Cash Flows Associated with Commercial Paper (Details) - USD ($) $ in Millions	3 Months Ended
	Dec. 25, 2021	Dec. 26, 2020
Maturities 90 days or less:
Proceeds from commercial paper, net	$ 1,339	$ 1,439
Maturities greater than 90 days:
Proceeds from commercial paper	1,191	780
Repayments of commercial paper	(3,530)	(2,197)
Repayments of commercial paper, net	(2,339)	(1,417)
Total proceeds from/(repayments of) commercial paper, net	$ (1,000)	$ 22

Shareholders' Equity - Addition

Shareholders' Equity - Additional Information (Details) shares in Millions	3 Months Ended
	Dec. 25, 2021USD ($)shares
Share Repurchase Program [Line Items]
Amount authorized for repurchase of common stock (up to)	$ 315,000,000,000
Number of shares repurchased (in shares) \| shares	124
Amount of share repurchases	$ 20,400,000,000
Share repurchase program, amount utilized	$ 274,500,000,000
November 2021 accelerated share repurchase agreements
Share Repurchase Program [Line Items]
Number of shares repurchased (in shares) \| shares	30
Amount of share repurchases	$ 6,000,000,000

Benefit Plans - Additional Info

Benefit Plans - Additional Information (Details) - USD ($) $ in Billions	3 Months Ended
	Dec. 25, 2021	Dec. 26, 2020
Share-based Compensation Arrangement by Share-based Payment Award [Line Items]
Total unrecognized compensation cost related to RSUs and stock options	$ 20.6
Total unrecognized compensation cost related to RSUs and stock options, weighted-average recognition period	3 years
Restricted stock units
Share-based Compensation Arrangement by Share-based Payment Award [Line Items]
Fair value of RSUs as of the respective vesting dates	$ 8.5	$ 8.5

Benefit Plans - Restricted Stoc

Benefit Plans - Restricted Stock Units Activity and Related Information (Details) - Restricted stock units $ / shares in Units, shares in Thousands, $ in Millions	3 Months Ended
	Dec. 25, 2021USD ($)$ / sharesshares
Number of Restricted Stock Units
Beginning balance (in shares) \| shares	240,427
RSUs granted (in shares) \| shares	67,645
RSUs vested (in shares) \| shares	(56,649)
RSUs canceled (in shares) \| shares	(4,886)
Ending balance (in shares) \| shares	246,537
Weighted-Average Grant Date Fair Value Per RSU
Beginning balance (in dollars per share) \| $ / shares	$ 75.16
RSUs granted (in dollars per share) \| $ / shares	147.33
RSUs vested (in dollars per share) \| $ / shares	61.75
RSUs canceled (in dollars per share) \| $ / shares	93.21
Ending balance (in dollars per share) \| $ / shares	$ 97.69
Aggregate Fair Value
Aggregate fair value of RSUs \| $	$ 43,460

Benefit Plans - Summary of Shar

Benefit Plans - Summary of Share-Based Compensation Expense and the Related Income Tax Benefit (Details) - USD ($) $ in Millions	3 Months Ended
	Dec. 25, 2021	Dec. 26, 2020
Share-based Payment Arrangement [Abstract]
Share-based compensation expense	$ 2,265	$ 2,020
Income tax benefit related to share-based compensation expense	$ (1,536)	$ (1,624)

Commitments and Contingencies -

Commitments and Contingencies - Changes in Accrued Warranties and Related Costs (Details) - USD ($) $ in Millions	3 Months Ended
	Dec. 25, 2021	Dec. 26, 2020
Changes in Accrued Warranties and Related Costs [Roll Forward]
Beginning accrued warranty and related costs	$ 3,364	$ 3,354
Cost of warranty claims	(672)	(723)
Accruals for product warranty	838	1,493
Ending accrued warranty and related costs	$ 3,530	$ 4,124

Segment Information and Geogr_3

Segment Information and Geographic Data - Information by Reportable Segment (Details) - USD ($) $ in Millions	3 Months Ended
	Dec. 25, 2021	Dec. 26, 2020
Segment Reporting Information [Line Items]
Net sales	$ 123,945	$ 111,439
Operating income	41,488	33,534
Americas
Segment Reporting Information [Line Items]
Net sales	51,496	46,310
Operating income	19,585	15,785
Europe
Segment Reporting Information [Line Items]
Net sales	29,749	27,306
Operating income	11,545	9,589
Greater China
Segment Reporting Information [Line Items]
Net sales	25,783	21,313
Operating income	11,183	8,530
Japan
Segment Reporting Information [Line Items]
Net sales	7,107	8,285
Operating income	3,349	3,503
Rest of Asia Pacific
Segment Reporting Information [Line Items]
Net sales	9,810	8,225
Operating income	$ 3,995	$ 2,953

Segment Information and Geogr_4

Segment Information and Geographic Data - Reconciliation of Segment Operating Income to the Condensed Consolidated Statements of Operations (Details) - USD ($) $ in Millions	3 Months Ended
	Dec. 25, 2021	Dec. 26, 2020
Segment Reporting, Reconciling Item for Operating Profit (Loss) from Segment to Consolidated [Line Items]
Operating income	$ 41,488	$ 33,534
Research and development expense	(6,306)	(5,163)
Operating segments
Segment Reporting, Reconciling Item for Operating Profit (Loss) from Segment to Consolidated [Line Items]
Operating income	49,657	40,360
Segment reconciling items
Segment Reporting, Reconciling Item for Operating Profit (Loss) from Segment to Consolidated [Line Items]
Research and development expense	(6,306)	(5,163)
Corporate non-segment
Segment Reporting, Reconciling Item for Operating Profit (Loss) from Segment to Consolidated [Line Items]
Other corporate expenses, net	$ (1,863)	$ (1,663)